# Breast Cancer Research Foundation

Source: https://onco.cc/institutions/bcrf/  
OnCo record `bcrf` (Institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

The largest private funder of breast cancer research worldwide, giving annual grants to more than 250 investigators across the field's leading centres.

## Summary

Founded in 1993 by Evelyn Lauder, the Breast Cancer Research Foundation funds investigators rather than projects, renewing annual grants to established scientists so they can pursue long-term questions in tumour biology, metastasis, prevention, survivorship and treatment. Its portfolio spans the major US and international centres, including Dana-Farber, MSK, the Royal Marsden and Peter Mac, and it co-funds the Translational Breast Cancer Research Consortium and the Evelyn H. Lauder Founder's Fund on metastasis. BCRF-supported researchers have contributed to CDK4/6 inhibitors, PARP inhibitors in BRCA carriers, immunotherapy in triple-negative disease and ctDNA-guided treatment. Funding figures are published in its annual report.

## Fields

- Kind: Institution
- Last checked: 2026-09-09
- Also known as: BCRF
- City: New York, US
- Type: consortium
- Website: https://www.bcrf.org

## Sources

- BCRF: https://www.bcrf.org
- About BCRF: https://www.bcrf.org/about-bcrf/

## Connected records

- collections: [Breast Cancer Research Foundation](https://onco.cc/collections/src-bcrf/)
- cancers: [HER2-positive breast cancer](https://onco.cc/cancers/breast-her2-positive/), [HR-positive / HER2-negative breast cancer](https://onco.cc/cancers/breast-hr-positive/), [Triple-negative breast cancer (TNBC)](https://onco.cc/cancers/tnbc/)
- technologies: [CDK4/6 inhibitors](https://onco.cc/technologies/cdk46-inhibitor/), [Liquid biopsy (ctDNA)](https://onco.cc/technologies/liquid-biopsy/), [PARP inhibitors](https://onco.cc/technologies/parp-inhibitor/)
- institutions: [Dana-Farber Brigham Cancer Center](https://onco.cc/institutions/dana-farber/), [Memorial Sloan Kettering Cancer Center](https://onco.cc/institutions/mskcc/), [Peter MacCallum Cancer Centre](https://onco.cc/institutions/peter-mac/), [The Royal Marsden](https://onco.cc/institutions/royal-marsden/)
- people: [Ann H. Partridge](https://onco.cc/people/ann-partridge/), [Donna McKay](https://onco.cc/people/donna-mckay/), [Dorraya El-Ashry](https://onco.cc/people/dorraya-el-ashry/), [Nancy U. Lin](https://onco.cc/people/nancy-lin/), [Nicholas Turner](https://onco.cc/people/nicholas-turner/), [Sara M. Tolaney](https://onco.cc/people/sara-tolaney/), [Sherene Loi](https://onco.cc/people/loi-sherene/)
- bottlenecks: [Metastasis is understood least and studied last](https://onco.cc/bottlenecks/b-metastasis-biology/)

---
JSON: https://onco.cc/api/v1/entities/bcrf.json